Showing results (2051-2060 of 2,173) with videos related to
Sort By:
Pageof 218
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 11, 2017
Reaching the limits of prognostication in non-small cell lung cancer: an optimized biomarker panel fails to outperform clinical parametersMarianna Grinberg, Dijana Djureinovic, Hans Rr Brunnström, et al.Contemporary Clinical Trials|May 14, 2022
Communication and Activation in Pain to Enhance Relationships and Treat Pain with Equity (COOPERATE): Rationale, study design, methods, and sample characteristicsMarianne S Matthias, Jasma Adams, Diana J Burgess, et al.Current Oncology (Toronto, Ont.)|March 12, 2019
Canadian consensus: oligoprogressive, pseudoprogressive, and oligometastatic non-small-cell lung cancerS A Laurie, S Banerji, N Blais, et al.Transplantation|April 1, 2011
Approaches to avoid immune responses induced by repeated subcutaneous injections of allogeneic umbilical cord tissue-derived cellsBram V Lutton, Patricia S Cho, Erica L Hirsh, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2011
Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myelomaDavid H Henry, Luis Costa, Francois Goldwasser, et al.Endoscopy|July 30, 2010
Evidence-based recommendations for bowel cleansing before colonoscopy in children: a report from a national working groupD Turner, A Levine, B Weiss, et al.Nature Cancer|November 11, 2024
The pro-oncogenic noncanonical activity of a RAS•GTP:RanGAP1 complex facilitates nuclear protein exportBrajendra K Tripathi, Nicole H Hirsh, Xiaolan Qian, et al.ACG Case Reports Journal|January 1, 2024
Amanita Mushroom Toxin Poisoning in Los Angeles CountyParker G Jobin, Connor Stewart, Aarshi Vipani, et al.The Patient|November 28, 2017
Does EGFR Mutation Type Influence Patient-Reported Outcomes in Patients with Advanced EGFR Mutation-Positive Non-Small-Cell Lung Cancer? Analysis of Two Large, Phase III Studies Comparing Afatinib with Chemotherapy (LUX-Lung 3 and LUX-Lung 6)Yi-Long Wu, Vera Hirsh, Lecia V Sequist, et al.Cancer Research Communications|November 16, 2022
Bcl-xL inhibition radiosensitizes PIK3CA/PTEN wild-type triple negative breast cancers with low Mcl-1 expressionAndrea M Pesch, Benjamin C Chandler, Anna R Michmerhuizen, et al.Pageof 218